You may recall back in the late 1980s and early 1990s, there was an avalanche of litigation stemming from leaking breast implants. These silicone implants did not last as manufacturers promised they would, and there were also accusations that companies failed to warn consumers of the possible hazards caused by ruptured implants. These included pain and soreness, change in breast size or shape and may be connected to joint problems, such as rheumatoid arthritis.
All this led to the U.S. Food & Drug Administration banning manufacture of silicone breast implants for nearly 15 years. That ban was lifted in 2006, with the FDA agreeing to authorize just three companies to sell silicone implants in the U.S. Last year, the breast implant market generated about $635 million – and 8 out of 10 customers opted for silicone implants.
Now, one of those companies, a subsidiary of Johnson & Johnson, is the target of litigation that some are saying could be the “tip of the iceberg” for a new onslaught of personal injury claims. Continue reading →